RACHEL HARLIN: Open Payments
NPI 1194476309 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 25 payments from 14 companies in 2025. Trend: 2023 $158 · 2024 $1,223 · 2025 $2,522
Food & beverage: $2,522
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $530 |
| Otsuka America Pharmaceutical, Inc. | 5 | $487 |
| E.R. Squibb & Sons, L.L.C. | 2 | $256 |
| Tris Pharma Inc | 2 | $243 |
| Amgen Inc. | 2 | $209 |
| AstraZeneca Pharmaceuticals LP | 1 | $127 |
| Exeltis, USA Inc. | 1 | $124 |
| GENZYME CORPORATION | 1 | $107 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| Neurocrine BioSciences, Inc. | 1 | $99 |
Products named: REXULTI, AUSTEDO XR, UZEDY, COBENFY, Dyanavel XR, TEZSPIRE, WAINUA, Auvelity.
Industry payments across MO — which companies pay providers there.
